Prior Stephen David

Prior Stephen David is listed in filings as Chief Strategy Officer at AN2 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 7, 2026, including sale activity. Recent filings connect the profile to AN2 Therapeutics, Inc. (ANTX). The current snapshot covers public activity from Nov 5, 2024 to Jan 7, 2026. Reported amounts are shown as $2.9K to $872. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.